DE602004016848D1 - Synergistische kombinationen enthaltend n-acylierte 4-hydroxyphenylamin derivate und koffein - Google Patents
Synergistische kombinationen enthaltend n-acylierte 4-hydroxyphenylamin derivate und koffeinInfo
- Publication number
- DE602004016848D1 DE602004016848D1 DE602004016848T DE602004016848T DE602004016848D1 DE 602004016848 D1 DE602004016848 D1 DE 602004016848D1 DE 602004016848 T DE602004016848 T DE 602004016848T DE 602004016848 T DE602004016848 T DE 602004016848T DE 602004016848 D1 DE602004016848 D1 DE 602004016848D1
- Authority
- DE
- Germany
- Prior art keywords
- acylated
- analgesic
- case
- combinations containing
- synergistic combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 title abstract 2
- 239000011885 synergistic combination Substances 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 abstract 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 206010019851 Hepatotoxicity Diseases 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 230000023555 blood coagulation Effects 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 231100000334 hepatotoxic Toxicity 0.000 abstract 1
- 230000003082 hepatotoxic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229940121367 non-opioid analgesics Drugs 0.000 abstract 1
- 239000000014 opioid analgesic Substances 0.000 abstract 1
- 229940005483 opioid analgesics Drugs 0.000 abstract 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical group C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seasonings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/459,911 US7064140B2 (en) | 2002-11-12 | 2003-06-12 | Synergistic combinations including N-acylated 4-Hydroxyphenylamine derivatives and caffeine |
| PCT/US2004/018514 WO2004110440A1 (en) | 2003-06-12 | 2004-06-10 | Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004016848D1 true DE602004016848D1 (de) | 2008-11-13 |
Family
ID=33510895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004016848T Expired - Lifetime DE602004016848D1 (de) | 2003-06-12 | 2004-06-10 | Synergistische kombinationen enthaltend n-acylierte 4-hydroxyphenylamin derivate und koffein |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7064140B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1635825B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2007503473A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE409478T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2004247138B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2531829A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE602004016848D1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2315679T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004110440A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006053012A2 (en) * | 2004-11-10 | 2006-05-18 | Trinity Laboratories, Inc. | Novel pharmaceutical compositions for treating acquired chronic pain and associated dysphoria |
| US8026266B2 (en) | 2005-11-08 | 2011-09-27 | Arcion Therapeutics, Inc. | Treatment of length dependent neuropathy |
| TWI392670B (zh) * | 2006-06-22 | 2013-04-11 | Ucb Pharma Gmbh | 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途 |
| EP2184986A4 (en) | 2007-08-06 | 2010-12-15 | Trinity Lab Inc | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554636A (en) * | 1995-04-21 | 1996-09-10 | Lsu Medical Center Foundation | N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them |
| US6864271B2 (en) * | 2002-11-12 | 2005-03-08 | The Foundation For The Lsu Health Sciences Center | Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives |
-
2003
- 2003-06-12 US US10/459,911 patent/US7064140B2/en not_active Expired - Lifetime
-
2004
- 2004-06-10 JP JP2006533699A patent/JP2007503473A/ja active Pending
- 2004-06-10 DE DE602004016848T patent/DE602004016848D1/de not_active Expired - Lifetime
- 2004-06-10 AU AU2004247138A patent/AU2004247138B2/en not_active Ceased
- 2004-06-10 WO PCT/US2004/018514 patent/WO2004110440A1/en not_active Ceased
- 2004-06-10 CA CA002531829A patent/CA2531829A1/en not_active Abandoned
- 2004-06-10 ES ES04754946T patent/ES2315679T3/es not_active Expired - Lifetime
- 2004-06-10 EP EP04754946A patent/EP1635825B1/en not_active Expired - Lifetime
- 2004-06-10 AT AT04754946T patent/ATE409478T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2315679T3 (es) | 2009-04-01 |
| CA2531829A1 (en) | 2004-12-23 |
| AU2004247138A1 (en) | 2004-12-23 |
| EP1635825A1 (en) | 2006-03-22 |
| ATE409478T1 (de) | 2008-10-15 |
| US7064140B2 (en) | 2006-06-20 |
| US20040254207A1 (en) | 2004-12-16 |
| EP1635825B1 (en) | 2008-10-01 |
| WO2004110440A1 (en) | 2004-12-23 |
| JP2007503473A (ja) | 2007-02-22 |
| AU2004247138B2 (en) | 2009-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327466D1 (de) | Synergistische zusammensetzungen mit analgetischen eigenschaften die eine n-acetylierte 4-hydroxyphenylamine derivate enthalten | |
| BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
| CY2013041I1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
| CY1118849T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| BRPI0519124A2 (pt) | composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço | |
| BR0313747A (pt) | Inibidores de transcriptase reversa de não-nucleosìdeo | |
| DE60143857D1 (de) | Zusammensetzung bestehend aus phy906 und chemotherapeutika | |
| ECSP066314A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
| TW200624427A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
| BR0211305A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto | |
| DE69823520D1 (de) | Noribogain zur behandlung von schmerzen und drogenabhängigkeit | |
| TW200626572A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| BRPI0418939A (pt) | derivados de nicotinamida e sua utilização como agentes terapêuticos | |
| NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
| DE602004006869D1 (de) | 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit | |
| BR9910899A (pt) | Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida | |
| BRPI0408295A (pt) | uso de um composto | |
| DE602004030604D1 (de) | N-(5-adamantane-1-yl-methoxy-pentyl)desoxynojirimycin oder eines pharmazeutischen salzes davon zur verwendung bei der behandlung der insulinresistenz | |
| ATE453617T1 (de) | Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien | |
| ATE409478T1 (de) | Synergistische kombinationen enthaltend n- acylierte 4-hydroxyphenylamin derivate und koffein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |